Pharma Insider Sells 4,772 Shares as 2025 Revenue Hits $883M
A high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
Indices summarize market segments and trends, helping investors gauge performance and set benchmarks. This overview covers their purpose and uses.
28,352 articlesA high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
Boeing's 777-9 promises a refreshed lineup and potential top-line growth, but does it justify investing in Boeing sto...
ServiceNow stock edged past the market as an analyst upgrade lifted sentiment. This article breaks down what moved NO...
A major fund recently disclosed a sizable stake in Boston Properties, sparking questions about what this move signals...
The latest quarterly results sparked a sharp drop in MercadoLibre shares. In this guide, we unpack why the stock just...
Grail stock surged on hype around early cancer-detection tests, then faded after a mixed trial result. This article a...
Could a Palantir competitor deliver the kind of upside that fans of AI software chase? This article breaks down the c...
SpaceX's move toward a public market future brings questions about lockups. This guide explains spacex lockup period:...
A CNBC analyst argues that a pivotal policy move on April 9 reshaped the S&P 500’s trajectory, turning volatility int...
Three stocks mispriced right could offer substantial upside for patient investors. This article breaks down why these...
A landmark deal sent Dominion Energy stock jumped after NextEra Energy offered a stock-for-stock combination. This ar...
When a hedge fund boosts its holdings, investors pay attention. This piece explains why Bridge City nearly tripled it...